PROCESSA PHARMACEUTICALS INC (PCSA) Stock Income Statement
NASDAQ:PCSA • US74275C4033
2.21 USD
+0.11 (+5.24%)
Last: Feb 26, 2026, 02:52 PM
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 13.02M | 12.00M | 11.46M | 20.26M | 11.57M | |||
| Research and Development | 7.41M | N/A | 5.80M | 10.71M | 6.09M | |||
| Selling, General, and Administrative Expenses | 5.61M | 4.78M | 5.66M | 8.76M | 4.69M | |||
| Operating Income | -13.02M | -12.00M | -11.46M | -20.26M | -11.57M | |||
| Interest Income/Expense | 87.80K | N/A | 335.50K | 101.20K | 11.60K | |||
| Non Recurring Items | N/A | N/A | 0.00 | -7.27M | -402.80K | |||
| Income Before Taxes | -12.93M | -12.00M | -11.12M | -27.42M | -11.96M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | -530.60K | |||
| Net Income | -12.93M | -12.00M | -11.12M | -27.42M | -11.43M | |||
| EBITDA | -13.02M | -12.00M | -11.46M | -19.47M | -10.78M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -34.99 | -98.03 | -211.99 | -851.15 | -372.96 | |||
| Non GAAP EPS | -34.00 | -97.25 | N/A | -625.00 | -370.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD